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Abstract
Axonal and synaptic degeneration occur following nerve injury and during disease. 
Traumatic nerve injury results in rapid fragmentation of the distal axon and loss of 
synaptic terminals, in a process known as Wallerian degeneration (WD). Identifying 
and understanding factors that influence the rate of WD is of significant biological and 
clinical importance, as it will facilitate understanding of the mechanisms of neurode-
generation and identification of novel therapeutic targets. Here, we investigate levels 
of synaptic loss following nerve injury under a range of conditions, including during 
postnatal development, in a range of anatomically distinct muscles and in a mouse 
model of motor neuron disease. By utilising an ex vivo model of nerve injury, we show 
that synaptic withdrawal is slower during early postnatal development. Significantly 
more neuromuscular junctions remained fully innervated in the cranial nerve/muscle 
preparations analysed at P15 than at P25. Furthermore, we demonstrate variability in 
the level of synaptic withdrawal in response to injury in different muscles, with retrac-
tion being slower in abdominal preparations than in cranial muscles across all time 
points analysed. Importantly, differences between the cranial and thoracoabdominal 
musculature seen here are not consistent with differences in muscle vulnerability that 
have been previously reported in mouse models of the childhood motor neuron dis-
ease, spinal muscular atrophy (SMA), caused by depletion of survival motor neuron 
protein (Smn). To further investigate the relationship between synaptic degeneration in 
SMA and WD, we induced WD in preparations from the Smn2B/− mouse model of SMA. 
In a disease-resistant muscle (rostral band of levator auris longus), where there is mini-
mal denervation, there was no change in the level of synaptic loss, which suggests that 
the process of synaptic withdrawal following injury is Smn-independent. However, in 
a muscle with ongoing degeneration (transvs. abdominis), the level of synaptic loss sig-
nificantly increased, with the percentage of denervated endplates increasing by 33% 
following injury, compared to disease alone. We therefore conclude that the presence 
of a die-back can accelerate synaptic loss after injury in Smn2B/− mice.
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1  | INTRODUC TION
Motor neurons are vulnerable to degeneration following phys-
ical or chemical injury and in a range of neurodegenerative 
diseases. Damaged axons and synapses degenerate in morpho-
logically distinct ways depending on the nature of the original 
trauma. Following injury, spontaneous and rapid fragmentation 
occurs along the length of the injured axon in a characteristic 
process known as Wallerian degeneration (WD; Waller, 1851; 
Beirowski et al., 2004, 2005; Conforti et al., 2014). In WD, 
the cytoskeleton is disassembled and granular degeneration 
proceeds distal to the injury site (for review see Wang et al., 
2012). This is morphologically distinct from degeneration that 
occurs during peripheral neuropathies, such as amyotrophic 
lateral sclerosis (ALS) and spinal muscular atrophy (SMA). In 
some forms of motor neuron disease, axons retrogradely retract 
away from the synaptic region and are described as ‘dying-back’ 
(Cavanagh, 1964). An example of dying-back pathology can be 
seen in the childhood motor neuron disease, SMA, where a lack 
of survival motor neuron (SMN) protein leads to the progressive 
loss of lower motor neurons (Lefebvre et al., 1995; Rodrigues 
et al., 1995). Despite morphological distinctions between WD 
and dying-back pathology, their mechanistic differences or 
commonalities remain unclear. Understanding whether differ-
ent morphologies also relate to different mechanisms would 
provide a powerful tool to better categorise different types of, 
neurodegeneration and potentially it will facilitate the identifi-
cation of novel therapeutic targets.
Recent work has revealed that rates of axonal and synaptic de-
generation are influenced by postnatal age. Significant differences 
in the response of neonatal vs. adult mice to peripheral nerve in-
jury and hypoxic insult have been reported (Murray et al., 2011). In 
young adult mice (P25), tibial nerve lesion results in a loss of motor 
nerve terminals within the deep lumbrical (DL) muscles, with just 
3% of motor endplates remaining innervated after 24 hr (Murray 
et al., 2011). Contrastingly, in mice aged less than 2 weeks of age, 
the rate of degeneration is much slower, with 86% of endplates 
remaining innervated after 24 hr (Murray et al., 2011). Synaptic 
loss in response to injury therefore appears to be developmen-
tally regulated in the DL muscles. Neonatal, murine neuromuscular 
junctions (NMJs) also remain structurally intact following expo-
sure to an ex vivo model of hypoxia reperfusion injury, with over 
99% of endplates remaining fully occupied in P2 murine transvs. 
abdominis (TVA), compared with just 4% in adult mice (Murray 
et al., 2011).
Differential rates of degeneration have been reported between 
different motor neurons pools in humans and in mouse models of 
motor neuron disease (Bowerman et al., 2012). Transcriptional 
profiling of differentially vulnerable motor neurons has identi-
fied transcripts and pathways which can modify the rate of de-
generation (Hedlund et al., 2010; Brockington et al., 2013; Kaplan 
et al., 2014; Comley et al., 2015; Murray et al., 2015; Kline et al., 
2017; Boyd et al., 2017). Properties that are intrinsic to the motor 
neuron may therefore regulate the rate of axon degeneration. 
Understanding the properties of different groups of motor neu-
rons should better inform us of the mechanisms of axon degenera-
tion. Due to the limited numbers of muscle that have been studied 
in detail, it remains unclear whether there is any variability in the 
rate of synaptic loss that occurs following injury in different mus-
cles. Determining how different pools of motor neurons respond 
to injury would provide a useful tool to investigate the factors that 
regulate WD, and how this relates to other types of axonal and 
synaptic degeneration.
It remains unclear whether developmental resistance to injury 
is unique to DL preparations. To investigate this, here we mea-
sured synaptic degeneration in cranial and thoracoabdominal 
musculature following nerve injury. This was achieved by using an 
ex vivo model of axon injury, where the nerve is transected, and 
the distal portion along with the musculature it innervates is re-
moved and maintained in oxygenated solutions for 24 hr (Brown 
et al., 2015; Kline et al., 2019). We have applied this model system 
to cranial muscle/facial nerve and abdominal muscle/intercostal 
nerve preparation at different postnatal time points. We show 
that there is a developmental delay in synaptic withdrawal follow-
ing injury in all cranial muscles. Interestingly, some muscles (such 
as adductor auris longus; AAL) showing significantly greater loss 
than other muscles of the same age (such as levator auris longus; 
LAL). Furthermore, synaptic degeneration was consistently re-
duced in the thoracoabdominal muscles compared to the cranial 
muscles. Together these data suggest that factors intrinsic to the 
muscle/motor neuron affect the degree of synaptic degeneration 
following injury. Comparison of the degree of synaptic loss fol-
lowing injury with the degree of synaptic loss in a mouse model 
of SMA, revealed strikingly different patterns. This suggests that 
the factors which affect the rate of synaptic degeneration follow-
ing injury are not the same as those which affect the vulnerability 
of motor neurons to SMA. Finally, by exposing muscles from the 
mouse model of SMA to the ex vivo model of nerve injury, we 
show that the presence of SMA-induced synaptic pathology sig-
nificantly increases synaptic loss following injury.
K E Y W O R D S
axotomy, developmental regulation, die-back, differential vulnerability, ex vivo, motor 
neuron disease, mouse model, neuromuscular disease, neuromuscular junction, peripheral 
neuropathy, postnatal development, spinal muscular atrophy, synaptic degeneration, Wallerian 
degeneration
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2  | METHODS
2.1 | Mouse maintenance
All animal procedures were performed in accordance with the UK Home 
Office and institutional guidelines. C57BL/6/J MCos1, C57BL/6 Smn2B/2B 
and Smn+/− mice were maintained as groups of less than four (or with 
parents/littermates) in individually ventilated cages under pathogen-
free conditions, with ad libitum access to food and water, on a 12:12 
light/dark cycle within animal facilities at the University of Edinburgh. 
MCos1 mice were sacrificed between P15-P25 and Smn2B/− mice were 
sacrificed at P18 (disease end-stage) by an inhalational overdose of an-
aesthetic (isofluorane). Death was confirmed by exsanguination of the 
carotid artery. The Smn2B/− mouse is a mouse model of the childhood 
motor neuron disease, spinal muscular atrophy that exhibits dying-back 
pathology. The Smn2B allele consists of a three-nucleotide substitu-
tion in the exon enhancer region within exon 7 of the murine Survival 
motor neuron (Smn) gene. The resultant mouse has reduced levels of 
full-length, endogenous SMN protein which leads to progressive loss 
of lower motor neurons (DiDonato et al., 2001; Hammond et al., 2010; 
Bowerman et al., 2012). Onset of disease signs occurs at around P10, 
and, in our colonies, this model has a lifespan of around 21 days.
2.2 | Ex vivo model of nerve injury
Cranial and abdominal nerve/muscle explants were dissected as de-
scribed previously (Murray et al., 2010a, 2014) in Hepes-buffered 
saline composed of NaCl (137 mM), KCl (5 mM), CaCl2·2H2O (2 mM), 
MgCl2·6H2O (1 mM), glucose (5.6 mM) and Hepes (5 mM) with pH cor-
rected to 7.4. Nerves (facial or intercostal) were severed at a consistent 
point, and distal nerve portions with attached musculature were pinned 
to dental wax and suspended in oxygenated mammalian physiologi-
cal saline containing: NaCl (120 mM), KCl (5 mM), CaCl2·2H2O (2 mM), 
MgCl2·6H2O (1 mM), NaH2PO4·2H2O (0.4 mM), NaHCO3 (23.8 mM), 
glucose (5.6 mM), gentamicin (50 mg/ml, Thermo Fisher) and kanamy-
cin (100 mg/ml, Thermo Fisher) in a 30-ml bijou tube. The bijou lid was 
modified, with two 0.8-mm needles, one needle clipped short, above 
the buffer level, to act as a pressure valve. A length of 0.50 mm tubing 
(VWR) sufficient to reach the bottom of the receptacle was attached 
to the other needle to provide a constant supply of 95/5% O2/CO2 to 
equilibrate the saline, at a perfusion rate of approximately 5 ml/min. 
The bathing solution was equilibrated for approximately 30 min before 
adding the sample. The receptacle containing the nerve/muscle ex-
plant was then incubated in a 30°C water bath for 24 hr. Temperature 
was monitored during this period using a digital thermometer (Fisher 
Traceable Digital Thermometer with stainless steel probe).
2.3 | Immunohistochemistry
After 24 hr incubation, preparations were fixed immediately in 
4% paraformaldehyde (EMS) for 15 min. Muscles of interest were 
microdissected and permeabilised in 2% Triton-X-100-PBS (Sigma; 
PBT) for 30 min on a rocking platform at room temperature. Blocking 
solution (4% bovine serum albumin [BSA]/1% PBT) was applied for 
60 min followed by primary antibodies (SV2, 1:100; 2H3, 1:50, both 
from Developmental Studies Hybridoma Bank) in blocking solution, 
and left to incubate at 4°C on a rocking platform for 24 hr. Preparations 
were then washed three times for 5 min with PBS. Secondary anti-
body (anti-mouse, Alexa Fluor 488, Stratech, 1:250 in 1×PBS) was 
added to each well and incubated in the dark at room temperature 
for a minimum of 4 hr. Muscles were washed three times in 1 × PBS 
for 5 min, and incubated with tetramethylrhodamine-conjugated 
α-bungarotoxin (TRITC-BTX; Thermo Fisher, 1:250, 20 min). Muscles 
were washed and whole-mounted on glass slides with Mowiol® 
(Calbiochem) and cover-slipped. Slides were stored in the dark at 4°C.
2.4 | Quantification and statistical analyses
Quantification of NMJ occupancy was undertaken by fluorescent 
microscopy at ×40 magnification. The investigator was blinded to 
the age, genotype and treatment of the muscle. A minimum of two 
to three fields of view (depending on muscle size and NMJ distribu-
tion) and 50 NMJs were sampled per muscle (average of 118 motor 
endplates per muscle). Fields of view were chosen at random from 
across the entire muscle using bungarotoxin staining only, to ensure 
a fair representation of the entire muscle and to reduce the chance 
of bias for innervated areas. A set of previously optimised and stand-
ardly used protocols for NMJ quantification were applied to quan-
tify the percentage of fully occupied endplates (Murray et al., 2008a, 
2011, 2013, 2015; Thomson et al., 2012; Sleigh et al., 2014a, 2014b; 
Brown et al., 2015; Comley et al., 2016; Kline et al., 2017; Courtney 
et al., 2019; Osman et al., 2019). In brief, fully occupied endplates 
were defined as complete apposition between the pre-synaptic ter-
minal and the motor endplate (see Figure 1a for example). This has 
been expressed as a percentage of the total number of endplates 
quantified for each muscle, with the remainder of endplates display-
ing synaptic withdrawal, appearing either only partially innervated 
(where only part of the AChR cluster is covered by a pre-synaptic 
terminal) or vacant (where no pre-synaptic staining is evident at the 
AChR cluster).
All morphological analyses were collated into Microsoft ExcEl 
before exporting to GraphPad Prism 8 software for statistical anal-
ysis with n numbers referring to the number of muscles analysed. 
Statistical tests are detailed in the legend of the relevant graphs to 
which they refer. Data were tested for normality using a Shapiro–
Wilk test. Data that were normally distributed were tested using one-
way analysis of variance (ANOVA) with post-hoc Tukey correction. 
In groups that were not normally distributed, Kruskal–Wallis tests 
with Dunn’s post-hoc analysis were applied. All data are presented as 
mean values ± standard error of the mean (SEM). Differences were 
considered significant when p < .05.
Micrographs are projections of Z-image stacks collected on a 
Nikon A1R FLIM confocal microscope and were adjusted for overall 
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image brightness and contrast only using imagEJ (downloadable 
from https://imagej.nih.gov/ij/) and Adobe PhotoshoP CS6 software 
(licence purchased from https://www.adobe.com/uk/produ cts/).
3  | RESULTS
3.1 | Synaptic loss following injury is 
developmentally regulated and non-uniform in cranial 
muscles of the mouse
It is unclear whether developmental regulation of synaptic loss in 
response to injury is unique to the DL muscles or whether devel-
opmentally regulated delays in synaptic withdrawal also occurs in 
other muscle preparations. We therefore examined rates of syn-
aptic withdrawal following injury during the critical time window 
of P15–P25, using an ex vivo model of nerve injury (see Section 2 
for details). Nerve-muscle preparations comprising facial nerve (CN 
VII) branches innervating the cranial musculature (comprising rostral 
and caudal bands of levator auris longus [LALr/LALc, respectively], 
abductor auris longus [AAL] and auricularis superior [AS]) were iso-
lated and maintained in oxygenated physiological solution at 30°C 
for 24 hr. We hypothesised that synapse loss would be slower in 
younger mice and that the level of synaptic loss would differ be-
tween different muscles. We tested this by analysing levels of mus-
cle innervation following 24-hr exposure to the ex vivo model of 
nerve injury at different postnatal ages.
The percentage of fully innervated or ‘occupied’ endplates re-
maining in immunostained muscles from P15–P25 mice, 24 hr after 
ex vivo nerve injury were quantified (Figure 1a–d). Note that all 
ages refer to the age at dissection. The data show that postnatal 
age affected the degree of synapse loss in all preparations analysed 
(Figure 1c). For example, at P15, the LALr remained highly innervated, 
with 77.05 ± 7.05% (mean ± SEM) of endplates covered by motor 
nerve terminals. As expected, levels of innervation 24 hr after injury 
declined with age to 58.75 ± 6.06% innervation in preparations from 
mice aged P18, to 13.81 ± 10.4% aged P21, and 7.53 ± 2.84% aged 
P24/5. The LALc and AS muscles followed similar patterns. However, 
we found significantly more denervated endplates in AAL from the 
outset, with only 23.56 ± 3.85% innervation remaining at P15. This 
declined with mouse age to 21.02 ± 4.96% at P18, whereas less than 
1.3% innervation remained at P21 and P24/5 (Figure 1d). As both 
AAL and LAL are homogeneously fast twitch muscles, these differ-
ences cannot be attributed to fibre type. This data suggests that 
there are other intrinsic properties of nerve or muscle that influence 
the rate of synaptic degeneration during postnatal development.
3.2 | Levels of synaptic loss are uniformly reduced 
in thoracoabdominal muscles of the mouse
Data thus far suggest that developmental delays are present in a 
range of muscles. However, differences between the rates of syn-
aptic withdrawal observed in the AAL at different time points, led us 
to ask whether there would be similar differences within thoracoab-
dominal musculature. To investigate the response to injury in these 
muscles, we examined the TVA and TS muscles 24 hr after ex vivo 
nerve injury using the same protocol as for cranial muscles. In con-
trast to cranial preparations, both the TVA and TS showed high levels 
of NMJ innervation across all time points analysed (Figure 2). There 
was no significant difference in the percentage of fully occupied 
endplates at any time point; in all cases, the muscle remained over 
77% innervated (one-way ANOVA with Tukey correction, p ≥ .09).
Taken together, the data indicate that there are properties in-
trinsic to the muscle.., and/or motor neuron, that can influence the 
extent of synaptic withdrawal in response to injury during the post-
natal period.
3.3 | Patterns of differential syanptic stability 
following injury contrast with patterns of selective 
vulnerability in a mouse model of SMA
Variability in the levels of synaptic degeneration, in a given muscle, 
has previously been reported in mouse models of motor neuron dis-
ease. For instance, in the Smn2B/− mouse model of SMA, the TVA 
muscle is highly vulnerable and displays high levels of synaptic loss, 
whereas the LALr and AAL muscles are relatively spared, with little 
F I G U R E  1   Synaptic stability following injury is developmentally regulated and non-uniform in cranial muscles of the mouse. (a) 
Representative confocal micrographs showing example NMJs to exemplify criteria for occupancy quantification. NMJs are labelled 
with antibodies against neurofilament (NF, green) and synaptic vesicle protein 2 (SV2, green), and α-bungarotoxin (BTX, red). The yellow 
arrowheads highlight endplates that would be quantified as ‘full’, whereas the pink arrowhead indicates a vacant endplate, where apposition 
between the pre-synaptic terminal and the motor endplate has been lost (see Methods for further detail). (b) Representative confocal 
micrographs showing NMJs labelled with antibodies against NF (green) and SV2 (green), and BTX (red) from cranial muscles (levator auris 
longus rostral/caudal band [LALr/c], abductor auris longus [AAL], auricularis superior [AS]) that have been maintained ex vivo at 30°C for 
24 hr. Postnatal age refers to the age of the animal at the time of dissection. Scale bar: 20 μm. (c) Bar charts showing quantification of 
the percentage of fully innervated motor endplates in cranial muscle bands between P15 and P24/5. Note that the percentage of fully 
occupied endplates decreases as postnatal age increases, supporting the finding that the response to injury is developmentally regulated. 
(d) Bar charts showing the percentage of fully occupied endplates in cranial muscles grouped by postnatal age at the time of ex vivo nerve 
injury. Note that there is a significant reduction in the percentage of fully occupied endplates in the AAL at both P15 and P18 time points in 
comparison with all other muscles. *p < .05, **p < .01, ***p < .001, ****p < .0001; one-way ANOVA with Tukey’s correction. n = 10 at P15 and 
P24/5; n = 18/6 for the LALr/all other muscles at P18; and n = 4/5 at P21 for the AAL/all other muscles. Error bars represent mean ± SEM
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synaptic loss ‘even at late stages of disease’ (Murray et al., 2015). To 
investigate how synaptic stability differs between disease and in-
jury, we compared levels of innervation remaining in muscles from 
end-stage (P18) Smn2B/− mice in vivo with levels of innervation re-
maining in homologous muscles from wild-type animals after ex vivo 
nerve injury. This provided insight into how synaptic responses dif-
fer following these distinct insults.
In line with previous work undertaken by Murray et al. (2015), 
here the LALr and AAL of Smn2B/− mice were largely spared from 
dying-back neuropathy in vivo, with over 98% of motor endplates 
remaining fully innervated at P18 (Figure 3). Contrasting this, 24 hr 
after ex vivo nerve injury in P18 wild-type mice, the LALr was 
47.23 ± 2.58% innervated and the AAL only 21.02 ± 4.96% inner-
vated (Figure 3). These cranial muscles therefore appear to ex-
hibit more extensive synaptic loss following injury than in an SMA 
mouse model (Mann–Whitney U-test, p ≤ .0007). Also in line with 
descriptions by Murray et al. (2015), in the Smn2B/− model, the TVA 
is vulnerable to dying-back pathology in vivo, with 62.11 ± 3.78% 
innervation remaining at P18, compared with 99.54 ± 0.29% 
innervated in wild-type age-matched mice 24 hr after ex vivo nerve 
injury (Figure 3). This suggests that the TVA exhibits less extensive 
synaptic loss following injury than in an SMA mouse model (Mann-
Whitney U test, p = .0002). Thus, the factors responsible for deter-
mining relative synaptic stability following both nerve injury and 
SMA, appear to be distinct.
3.4 | Reduced Smn levels do not influence the 
incidence of synaptic loss following injury in the LALr 
cranial muscle of the mouse
We next asked whether a reduction in Smn levels affects synaptic 
stability after injury. To address this, we isolated and maintained 
cranial nerve/muscle preparations from wild-type mice and from 
Smn2B/− mice. In Smn2B/− mice, cranial muscles are classified as se-
lectively resistant, in that even at end-stage of disease, there is no 
synapse loss evident (cf. Figure 3). Therefore, these muscles have 
reduced Smn levels but no resultant synaptic loss (Murray et al., 
F I G U R E  2   Minimal synaptic loss is observed following injury across all time points analysed in thoracoabdominal musculature. (a) 
Representative confocal micrographs showing NMJs labelled with antibodies against neurofilament (NF, green) and synaptic vesicle protein 
2 (SV2, green), and α-bungarotoxin (BTX, red) from transvs. abdominis [TVA] and triangularis sterni (TS) muscles which have been maintained 
ex vivo at 30°C for 24 hr. Postnatal age refers to the age of the animal at the time of dissection. Note that the majority of endplates remain 
fully occupied at all ages examined. Scale bar: 20 μm. (b) Bar charts showing quantification of the percentage of fully innervated motor 
endplates after ex vivo nerve injury in the TVA and TS at P15, P18, P21, and P24/5. The percentage of fully occupied endplates remains high 
across all time points and there is no significant difference within muscles at any time point. ns = not significant, p ≥ .09; one-way ANOVA 
with Tukey’s correction. TVA, n = 6, 18, 4, and 6 muscles, at P15, 18, 21, and 24/5, respectively, and n = 6, 6, 6, and 4 in the TS at P15, 18, 
21, and 24/5, respectively. Error bars represent mean ± SEM
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2015). We compared levels of denervation in the LALr under three 
conditions: LALr from wild type after ex vivo nerve injury; LALr from 
Smn2B/−; and LALr from Smn2B/− after ex vivo nerve injury.
In this disease-resistant muscle, consistent with previous work 
by Murray et al. (2015), minimal denervation was found in vivo in 
Smn2B/− mice, with over 93% of endplates remaining fully occupied. 
In wild-type mice, ex vivo nerve injury-induced extensive dener-
vation, with 47.12 ± 4.08% of endplates remaining fully occupied. 
In muscles from Smn2B/− mice subject to ex vivo nerve injury, we 
found that the level of synaptic loss was comparable to wild-type 
levels, where 58.55 ± 3.528% of endplates remaining fully occupied 
(Unpaired t-test with Welch’s correction, p = .087; Figure 4). We con-
clude that in the LALr, where synapse loss due to Smn deficiency is 
minimal, the synaptic loss caused by nerve injury is not altered. As 
Smn levels are reduced in this model, despite the lack of NMJ pathol-
ogy, we conclude that synaptic withdrawal following ex vivo nerve 
injury is Smn-independent.
3.5 | The presence of dying-back pathology 
increases the level of synaptic loss following injury 
in the TVA muscle of the mouse
To investigate the relationship between synaptic loss that occurs 
in injury vs. disease, we also investigated whether there was any 
alteration in the level of synaptic loss following injury in the pres-
ence of dying-back pathology. Unlike the LALr, the TVA muscle of 
the Smn2B/− mouse model exhibits high levels of synaptic pathol-
ogy, including denervation, pre-synaptic swelling, and post-synaptic 
shrinkage at end-stages of disease (P18). We compared levels of 
denervation in the TVA under three conditions at P18: TVA from 
wild type after ex vivo nerve injury; TVA from Smn2B/−; and TVA from 
Smn2B/− after ex vivo nerve injury.
Ex vivo nerve injury of the TVA muscle from Smn2B/− mice resulted 
in a significant reduction in the percentage of fully occupied end-
plates, to just 8.05 ± 6.23% in comparison with wild-type TVA with 
ex vivo nerve injury (98.53 ± 0.29% of endplates fully innervated, 
Kruskal–Wallis with Dunn’s correction, p < .0001) and to Smn2B/− in 
vivo (41.11 ± 3.98% of endplates fully innervated, Unpaired t-test 
with Welch’s correction, p = .0018) in isolation (Figure 5). Overall, as 
we have already established that SMN reduction alone is not suffi-
cient to increase levels of synaptic loss, it follows that the increase in 
synapse loss observed here is induced by the presence of disease-in-
duced synaptic pathology.
4  | DISCUSSION
In this study, we have applied an ex vivo assay to investigate the 
effect of traumatic nerve injury in a range of muscles that have not 
F I G U R E  3   Synaptic stability is different in response to disease or injury conditions. (a) Representative confocal micrographs showing 
NMJs labelled with antibodies against neurofilament (NF, green) and synaptic vesicle protein 2 (SV2, green), and α-bungarotoxin (BTX, red) 
showing innervation of abductor auris longus (AAL), levator auris longus rostral band (LALr), and transvs. abdominis (TVA) under disease 
conditions from Smn2B/− mice at P18 and following ex vivo nerve injury in wild-type animals at P18. Nerve/muscle explants from the ‘nerve 
injury’ group were maintained ex vivo at 30°C for 24 hr. Scale bar: 20 μm. (b) Bar chart showing quantification of the percentage of fully 
innervated motor endplates in the AAL, LALr, and TVA after ex vivo nerve injury in WT vs. Smn2B/− mice. In the Smn2B/− mouse, the LALr 
and AAL cranial muscles are spared from degeneration in comparison with the TVA muscle. Following ex vivo nerve injury, LALr and AAL 
show high levels of synapse loss, whereas the TVA appears preserved. ns = not significant, ***p < .001; Mann–Whitney U-test. Note that for 
the AAL, n = 9, 6; for the LALr, n = 8, 6; and for the TVA, n = 10, 6 muscles for Smn2B/− and nerve injury/WT groups, respectively. Error bars 
represent mean ± SEM
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been examined in this context previously. We have demonstrated 
that postnatal maturity influences the synaptic stability following 
injury in the cranial muscles. We have also shown that levels of 
synaptic loss are non-uniform in these muscles, with a significant 
increase in the rate of synaptic withdrawal in response to injury in 
the AAL at younger ages when compared with other cranial muscles. 
We also found that high levels of innervation persisted in the thora-
coabdominal muscles after injury across P15–P25. This suggests 
that muscle and/or motor neuron intrinsic properties affect synaptic 
stability following injury. Comparison of the patterns of relative syn-
aptic stability following injury to the patterns of synaptic vulnerabil-
ity in a mouse model of SMA further suggests that the factors which 
affect synaptic stability following injury are distinct from those in 
peripheral neuropathies such as SMA. By exposing a muscle from a 
mouse model of SMA that is resistant to dying-back pathology with 
the ex vivo nerve injury assay, we have shown that synaptic loss in 
response to injury is SMN-independent. Furthermore, exposure of 
a muscle with ongoing dying-back pathology to the ex vivo nerve 
injury assay has demonstrated that the presence of dying-back pa-
thology accelerates the rate of synaptic loss in response to injury.
4.1 | Synaptic stability following injury is governed 
by properties intrinsic to the muscle and/or 
motor neuron
We have shown that synaptic withdrawal in response to injury can 
be influenced by developmental age. Across all four cranial muscles 
analysed, we observed an increase in the incidence of denervated 
endplates with increasing postnatal age. These findings are in line with 
previous work that has shown that following either peripheral nerve 
injury or hypoxic insult, resistance is gradually lost across the first few 
weeks of life as the muscle transitions to adult levels of vulnerability 
(Murray et al., 2011). Furthermore, some muscles, like the AAL, reach 
adult levels of degeneration at an earlier time point, whereas others, 
such as the TVA, remain comparatively stable following injury, even 
at P25 (Murray et al., 2011). This suggests that postnatal maturity as 
well as properties specific to the muscle and/or motor neuron, are ca-
pable of regulating synaptic degeneration following insult. Discerning 
these mechanisms would be of great value and would contribute sig-
nificantly to our understanding of the mechanisms regulating synap-
tic stability and vulnerability to injury and disease.
Indeed, various genetic mutations have been shown to alter the 
rate of WD in animal models, and have massively increased our un-
derstanding of the mechanisms of WD. This includes Wlds and Sterile 
Alpha and TIR motif-containing 1 (SARM1) knockout (Lunn et al., 
1989; Ribchester et al., 1995; Mack et al., 2001; Wang et al., 2001; 
Gillingwater et al., 2002, 2004, 2006; Coleman, 2005; Coleman and 
Freeman, 2010; Gilley and Coleman, 2010; Osterloh et al., 2012; Di 
Stefano et al., 2015; Gilley et al., 2015). Furthermore, differences in 
synaptic vulnerability in motor neuron disease have been exploited 
to investigate the underlying factors that may be responsible making 
motor neurons vulnerable in motor neuron disease. Transcriptional 
profiling of differentially vulnerable motor neurons has helped identify 
transcripts and pathways which can modify the rate of degeneration 
(Hedlund et al., 2010; Brockington et al., 2013; Kaplan et al., 2014; 
F I G U R E  4   Reduced Smn levels have no effect on the level of synaptic degeneration following injury in the LALr cranial muscle of the 
mouse. (a) Representative confocal micrographs showing NMJs labelled with antibodies against neurofilament (NF, green) and synaptic 
vesicle protein 2 (SV2, green), and α-bungarotoxin (BTX, red) from levator auris longus rostral band (LALr) in wild-type animals after ex 
vivo nerve injury (nerve injury/WT), in Smn2B/− mice and in Smn2B/− mice after ex vivo nerve injury (nerve injury/Smn2B/−). In nerve injury/
WT and nerve injury/Smn2B/− conditions, LALr muscles were maintained ex vivo at 30°C for 24 hr. Scale bar: 20 μm. (b) Bar charts showing 
quantification of the percentage of fully occupied endplates in LALr in nerve injury/WT, Smn2B/−, and nerve injury/Smn2B/− conditions. The 
percentage of fully occupied endplates after nerve injury in Smn2B/− mice is not significantly different than after nerve injury in wild-type 
animals. *p < .05, ***p < .001, ns = not significant. For all comparisons with the Smn2B/− group, Kruskal–Wallis with Dunn’s correction was 
used to account for non-normally distributed data; otherwise a one-way ANOVA with Tukey’s correction was used. Note that n = 6, 8, 6 for 
the nerve injury/WT, Smn2B/− and nerve injury/Smn2B/− groups, respectively. Error bars: mean ± SEM
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Comley et al., 2015; Murray et al., 2015; Boyd et al., 2017; Kline et al., 
2017). We have recently used this approach to identify alpha-synuclein 
and stathmin 1 as phenotypic modifiers of pathology in motor neu-
ron diseases. Importantly, when levels of alpha-synuclein or stathmin 
1 were increased, disease severity was reduced and NMJ pathology 
ameliorated (Kline et al., 2017; Villalon et al., 2019). Identification of 
motor neurons that are differentially affected during axon degenera-
tion therefore serves as a useful tool to identify factors that can modify 
axon degeneration in both disease and injury.
Here we have shown that muscle and/or motor neuron-specific 
properties are another factor that can influence the rate of synap-
tic loss, with responses varying between muscles. This is unlikely to 
be attributed to muscle fibre type. For example, both LAL and AAL 
are predominantly fast twitch muscles, but they display a marked 
difference in synaptic stability following injury (Erzen et al., 2000; 
Murray et al., 2008a, 2010a, 2010b). In wild-type rats and in Wlds 
mice, the rate of synaptic loss has also been shown to be dependent 
on nerve stump length, with failure of neuromuscular transmission 
occurring more rapidly when nerve stump length is shorter (Slater, 
1966; Ribchester et al., 1995). However, the differences we have 
reported here cannot be attributed to differences in nerve stump 
length, as stump length is the same for all of the cranial muscles.
A promising avenue which may explain the differing synaptic 
stability following injury in different muscles at different postnatal 
ages, is differences in mitochondrial bioenergetics. In a recent study, 
we have profiled the nerve and muscle proteome in tibial nerve/
lumbrical muscles between P12 and P24, and report a consistent 
up-regulation in proteins involved with mitochondrial bioenergetics 
in both muscle and nerve. Interestingly, this same profile has been ob-
served in the tibialis anterior muscle, and during postnatal develop-
ment of the heart (Puente et al., 2014; Kim et al., 2019). Importantly, 
we further showed that inhibition of complex I of the mitochondrial 
respiratory chain could slow axon degeneration, whereas pharmaco-
logical activation of oxidative phosphorylation accelerated synaptic 
degeneration (Kline et al., 2019). It will now be important to investi-
gate mitochondrial bioenergetics in the range of ages and muscles 
investigated in this study, to determine whether this can explain 
the differences in synaptic stability observed. This will help identify 
factors responsible for conferring rate differences and will provide 
insight into the mechanisms of synaptic degeneration, and aid in the 
identification of targets to manipulate the rate of degeneration.
4.2 | Mechanisms of synaptic loss following injury 
vs. dying-back neuropathy
Following traumatic injury in the Smn2B/− mouse model of SMA, we 
assessed the influence on the level of synaptic loss. Differential vul-
nerability is a known feature in this disease model, therefore we in-
vestigated both a die-back-resistant (LALr) and die-back-vulnerable 
(TVA) muscle (Murray et al., 2015). As synaptic withdrawal after in-
jury was amplified in the presence of a die-back, we conclude that 
the presence of dying-back pathology can increase synaptic loss in 
following injury.
F I G U R E  5   Presence of synaptic pathology in the Smn2B/− mouse significantly amplifies the level of synaptic loss induced by injury in the 
TVA muscle. (a) Representative confocal micrographs showing NMJs labelled with antibodies against neurofilament (NF, green) and synaptic 
vesicle protein 2 (SV2, green), and α-bungarotoxin (BTX, red) from transvs. abdominis (TVA) at P18 in wild-type animals after ex vivo 
nerve injury (nerve injury/WT), in the Smn2B/− mice, and in Smn2B/− after ex vivo nerve injury (nerve injury/Smn2B/) conditions, respectively. 
In ex vivo conditions, TVA muscles were maintained ex vivo at 30°C for 24 hr. P18 refers to the postnatal age of the animal at the time 
of dissection. Scale bar: 20 μm. (b) Bar charts showing quantification of the percentage of fully occupied endplates in the TVA in nerve 
injury/WT, Smn2B/−, and nerve injury/Smn2B/− conditions. The percentage of fully occupied endplates following injury in Smn2B/− mice was 
significantly increased in comparison with either wild-type injury or Smn2B/− conditions in isolation. *p < .05, **p < .01, ****p < .0001. For all 
comparisons with the nerve injury/WT group, Kruskal–Wallis with Dunn’s correction was used to account for non-normally distributed data, 
otherwise a one-way ANOVA with Tukey’s correction was used. Note that n = 6, 10, 6 muscles for the nerve injury/WT, Smn2B/−, and nerve 
injury/Smn2B/− groups, respectively. Error bars: mean ± SEM
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Our results are perhaps initially surprising based on previous 
work where the presence of dying-back pathology reduced synaptic 
loss and axon fragmentation following nerve injury. In Wasted mice, 
which display a dying-back neuromuscular phenotype, translation 
elongation factor eEF1A2 expression is required to prevent dy-
ing-back pathology at the NMJ, whereas loss of this factor inhibits 
the initiation and progression of WD (Murray et al., 2008b). Although 
differing requirements for eEF1A2 expression may represent a 
mechanistic distinction between injury-induced degeneration and 
dying-back pathology, this does not exclude the possible occurrence 
of convergence in degenerative pathways further downstream.
Commonalities between WD and dying-back neuropathies 
have been reported in animal models of motor neuron disease. 
For example, Wlds has been found to be protective in some motor 
neuron disease and peripheral neuropathy models, suggesting 
that there may be some convergence between degenerative 
mechanisms. Similarly, in mice with progressive motor neuronop-
athy, Wlds expression also delays dying-back pathology (Ferri 
et al., 2003). Delays have also been reported in animal models 
of Parkinson’s and demyelinating diseases (Conforti et al., 2014). 
Several similarities have also been highlighted at the cellular level 
between WD and dying-back pathology, including poor axonal 
transport, mitochondrial dysfunction, and an increase in intra-ax-
onal calcium (for review see Coleman, 2005; Conforti et al., 2014). 
Our recent proteomic work in mice has identified alterations in 
mitochondrial bioenergetics that coincide with delays in the 
change in level of synaptic loss in response to injury during post-
natal development in the hindlimb (Kline et al., 2019). Targeting 
bioenergetic pathways by enhancing mitochondrial bioenergetics 
has also been found to rescue motor axon defects in a model of 
SMA (Boyd et al., 2017). Alterations in mitochondrial dynamics 
may therefore represent a promising, and perhaps uniting factor 
in WD and dying-back neuropathy. Overall, the identification 
of common factors capable of influencing the rate of neurode-
generation under different physiological conditions could aid in 
the identification of targets that are common across multiple 
diseases.
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